Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) |
Gene mutation,
Introduction of a transgene
|
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 24805991 |
MR4 number |
|
top of page |
Parent parasite used to introduce the genetic modification |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone |
P. berghei ANKA 507cl1 (RMgm-7)
|
Other information parent line | P.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190). |
top of page |
The mutant parasite was generated by |
Name PI/Researcher | Tewari R; Baker DA |
Name Group/Department | Department of Pathogen Molecular Biology |
Name Institute | Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine |
City | London |
Country | UK |
top of page |
Name of the mutant parasite |
RMgm number | RMgm-1094 |
Principal name | Pb(pfpkg) |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page |
Phenotype |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Normal numbers of gametocytes. Normal rates of exflagellation. Strongly reduced ookinete formation (ookinete conversion rates of wild typpe 63% and of the mutant 10%) |
Oocyst | Normal numbers of gametocytes. Normal rates of exflagellation. Strongly reduced ookinete formation (ookinete conversion rates of wild typpe 63% and of the mutant 10%. Reduced oocyst production. |
Sporozoite | Normal numbers of gametocytes. Normal rates of exflagellation. Strongly reduced ookinete formation (ookinete conversion rates of wild typpe 63% and of the mutant 10%. Reduced oocyst production. No sporozoites in salivary glands. |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation
In the mutants the endogenous pkg gene has been replaced by the orthologous pkg gene of P. falciparum. In addition the mutant expresses GFP under the constitutive eef1a promoter
Protein (function)
Cyclic GMP-dependent protein kinases (PKGs) are the major mediators of the cGMP signal transduction pathway and regulate a variety of physiological effects. PKG is is a serinethreonine kinase that transfers the γ-phosphate of ATP, in a cGMP-dependent manner, to a variety of substrate proteins.
Evidence has been presented that in Plasmodium species that activation of PKG is critically required to regulate cytosolic Ca2+ levels. PKG emerges as a universal regulator that controls ookinete gliding, gametocyte activation, and schizont rupture.
Phenotype
Phenotype analyses indicate that PfPKG can functionally complement PbPKG in asexual blood stages of Pbpfpkg parasites, as well as in gametocyte development and male gametogenesis, replacement of the endogenous gene with PfPKG leads to a decreased conversion into ookinete stages, reduced oocyst production and no detectable sporozoites causing a block of parasite transmission in the mosquito.
Additional information
The mutant can be useful for in vivo screening future generations of cyclic GMPdependent protein kinase inhibitors and allowing to overcome any species-specific differences in the enzyme primary sequence that would influence in vivo efficacy in the rodent model.
Other mutants
See this link
|